Elaine J. Abrams

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 717 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/mL

John P. A. Ioannidis, Elaine J. Abrams, A. J. Ammann et al. · The Journal of Infectious Diseases · 2001 · 379 citations

Public Health, Infectious Diseases, Maternal Health +17

Use of the Polymerase Chain Reaction for Early Detection of the Proviral Sequences of Human Immunodeficiency Virus in Infants Born to Seropositive Mothers

Martha F. Rogers, Chin‐Yih Ou, Mark A. Rayfield et al. · New England Journal of Medicine · 1989 · 349 citations

Medicine, Infectious Diseases, Pediatrics +17

Clinical Outcomes and CD4 Cell Response in Children Receiving Antiretroviral Therapy at Primary Health Care Facilities in Zambia

Carolyn Bolton‐Moore, Mwangelwa Mubiana‐Mbewe, Ronald A. Cantrell et al. · JAMA · 2007 · 337 citations

Public Health, Pediatric Nursing, Pediatrics +17

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 260 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17